Preparation and application of a 5-bromoquinazoline derivative

US11840537B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11840537-B2
Application numberUS-202117488317-A
CountryUS
Kind codeB2
Filing dateSep 29, 2021
Priority dateNov 3, 2020
Publication dateDec 12, 2023
Grant dateDec 12, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A 5-bromoquinazoline derivative (I), structural formula thereof is as follows: the synthesis method thereof comprises weighing 1.18 g of 5-bromoisatin, 2.5503 g of ammonium formate and 100 ml of absolute methanol in a 250 mL round-bottom flask, heating, stirring and refluxing for 48 h, stopping reaction, rotating to obtain 1.6033 g of filter residue crude product, carrying out column chromatography separation by using dichloromethane and absolute methanol according to a volume ratio of 1:1, and obtaining a target crystal compound I; the application of the 5-bromoquinazoline derivative compound crystal (I), as a catalyst has a good catalytic effect in nitrile silicification reaction of benzaldehyde and auto-polymerization reaction of benzophenone hydrazone, the conversion rates thereof respectively reach 39% and 76%, and the crystal (I) can be used as an anti-cancer reagent which has certain anti-cancer activity of breast cancer, liver cancer and lung cancer.

First claim

Opening claim text (preview).

The invention claimed is: 1. A 5-bromoquinazoline derivative (I), structural formula thereof is as follows: 2. The 5-bromoquinazoline derivative crystal (I) of claim 1 , at the temperature of 293(2) K, and on the Oxford X-ray single crystal diffractometer, diffraction data is collected by w-O scanning mode with MoKα rays (λ=0.71073 Å) monochromatized by a graphite monochromator, wherein the crystal belongs to the triclinic system, P-1, cell parameters: a=8.7881(5) Å alpha=98.254(2)deg; b=9.9375(5) Å beta=97.014(2)deg; c=17.8389(9) Å gamma=112.154deg. 3. A synthesis method of the 5-bromoquinazoline derivative compound (I) of claim 1 , comprising heating 5-bromoisatin and ammonium formate in absolute methanol to obtain the final product. 4. A method of synthesizing benzyloxy-trimethylsilane, comprising reacting benzaldehyde and TMSCN with a catalyst of formula (I) according to claim 1 in THF at room temperature to obtain the product. 5. A method of synthesizing 1,2-bis(diphenylmethylene)hydrazine, comprising heating a reaction of benzophenone hydrazone with a catalyst of formula (I) according to claim 1 in methanol to obtain the product.

Assignees

Inventors

Classifications

  • C07D487/10Primary

    Spiro-condensed systems · CPC title

  • of ether, acetal or ketal groups · CPC title

  • Crystalline forms, e.g. polymorphs · CPC title

  • Antineoplastic agents · CPC title

  • also containing elements or functional groups covered by B01J31/0201 - B01J31/0231 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11840537B2 cover?
A 5-bromoquinazoline derivative (I), structural formula thereof is as follows: the synthesis method thereof comprises weighing 1.18 g of 5-bromoisatin, 2.5503 g of ammonium formate and 100 ml of absolute methanol in a 250 mL round-bottom flask, heating, stirring and refluxing for 48 h, stopping reaction, rotating to obtain 1.6033 g of filter residue crude product, car…
Who is the assignee on this patent?
Luo Mei, Univ Hefei Technology
What technology area does this patent fall under?
Primary CPC classification C07D487/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).